Research On Business Model For Chengdu International Contract-Research Tech Co.

In recent years, with increasing complexity of new drug.development and continuous improvement of drug management, R&D costs are rising essentially straight line projections of current trends. Many European and American pharmaceutical companies have put new drug development in non-core part of the business was spun off from their own, transfer or direct outsourcing to developing countries. The current R&D outsourcing service industry is frantic enthusiasm in china now. In this paper, we'll explore the Chengdu International Contract-Research Tech Co., Ltd., which is a company of pharmaceutical outsourcing industry and software design industry, analyzing of its business strategy and determining a viable business model by the feasibility of the main product ICR-CRO, and the company's current situation and business environment, and the core competitiveness and so on.